September 25, 2019
The Ministry of Health, Labor and Welfare (MHLW) on September 24 ordered label revisions related to adverse reactions for a thong of medicines including Chugai Pharmaceutical’s rheumatoid arthritis (RA) drug Actemra (tocilizumab) and AstraZeneca’s lung cancer medicine Tagrisso (osimertinib). In...read more